BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.22−0.16 (-11.59%)
Close on Nov 17, 2026Market cap $27.65MP/E –Yield –
BioHarvest Sciences r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $5.31M, up 10.7% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.31M | +10.7% |
| FY2024 | Dec 31, 2024 | $4.80M | +42.4% |
| FY2023 | Dec 31, 2023 | $3.37M | – |
See a number that looks wrong?